| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/23/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 4.2k | $0.00 | $0 | | 05/23/2023 |
| 05/12/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Payment of Exercise | Common Stock | 6.1k | $93.93 | $576.4k | | 05/12/2023 |
| 05/12/2023 | BIOMARIN PHARMACEUTICAL INC | BMRN | Exercise | Stock Option (Right to Buy Common Stock) | 8.5k | $67.81 | $576.4k | | 05/12/2023 |
| 05/24/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 5k | $0.00 | $0 | | 05/24/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Common Stock | 57.2k | $28.25 | $1.6M | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Common Stock | 65.8k | $28.25 | $1.9M | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Common Stock | 40.6k | $28.25 | $1.1M | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Options (Right to buy) | 34k | $23.07 | $784.4k | | 05/13/2022 |
| 05/13/2022 | Intersect ENT, Inc. | XENT | Other | Stock Options (Right to buy) | 74.9k | $21.60 | $1.6M | | 05/13/2022 |
| 05/02/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Exercise | Stock Option (Right to buy Common Stock) | 8.5k | $37.46 | $318.4k | | 05/02/2022 |
| 05/02/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Sale | Common Stock | 18 | $82.12 | $1.5k | | 05/02/2022 |
| 05/02/2022 | BIOMARIN PHARMACEUTICAL INC | BMRN | Sale | Common Stock | 3.9k | $82.09 | $316.9k | | 05/02/2022 |
| 02/02/2022 | Intersect ENT, Inc. | XENT | Payment of Exercise | Common Stock | 2.3k | $27.31 | $63.6k | | 02/01/2022 |
| 02/01/2022 | Intersect ENT, Inc. | XENT | Grant | | 36.7k | $0.00 | $0 | | 02/01/2022 |
| 11/29/2021 | Intersect ENT, Inc. | XENT | Payment of Exercise | Common Stock | 6.3k | $26.94 | $171k | | 11/29/2021 |
| 05/25/2021 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 5.1k | $0.00 | $0 | | 05/25/2021 |
| 05/06/2021 | BIOMARIN PHARMACEUTICAL INC | BMRN | Exercise | Stock Option (Right to buy Common Stock) | 15k | $26.49 | $397.4k | | 05/06/2021 |
| 05/06/2021 | BIOMARIN PHARMACEUTICAL INC | BMRN | Sale | Common Stock | 5.1k | $78.38 | $397.2k | | 05/06/2021 |
| 02/01/2021 | Intersect ENT, Inc. | XENT | Grant | | 17.4k | $0.00 | $0 | | 02/01/2021 |
| 02/01/2021 | Intersect ENT, Inc. | XENT | Grant | Stock Options (Right to buy) | 34k | $23.07 | $784.4k | | 02/01/2021 |
| 11/27/2020 | Intersect ENT, Inc. | XENT | Payment of Exercise | Common Stock | 6.3k | $20.00 | $127k | | 11/27/2020 |
| 05/27/2020 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 4.3k | $0.00 | $0 | | 05/27/2020 |
| 03/17/2020 | Intersect ENT, Inc. | XENT | Purchase | Common Stock | 5k | $7.80 | $39k | | 03/17/2020 |
| 03/16/2020 | Intersect ENT, Inc. | XENT | Purchase | Common Stock | 2.5k | $13.75 | $34.4k | | 03/16/2020 |
| 03/16/2020 | Intersect ENT, Inc. | XENT | Purchase | Common Stock | 2.5k | $13.50 | $33.8k | | 03/16/2020 |
| 03/16/2020 | Intersect ENT, Inc. | XENT | Purchase | Common Stock | 2.5k | $12.75 | $31.9k | | 03/16/2020 |
| 03/16/2020 | Intersect ENT, Inc. | XENT | Purchase | Common Stock | 2.5k | $10.19 | $25.5k | | 03/16/2020 |
| 11/26/2019 | Intersect ENT, Inc. | XENT | Grant | | 52.2k | $0.00 | $0 | | 11/26/2019 |
| 11/26/2019 | Intersect ENT, Inc. | XENT | Grant | | 57.2k | $0.00 | $0 | | 11/26/2019 |
| 11/26/2019 | Intersect ENT, Inc. | XENT | Grant | Stock Options (Right to buy) | 74.9k | $21.60 | $1.6M | | 11/26/2019 |
| 06/11/2019 | BIOMARIN PHARMACEUTICAL INC | BMRN | Gift | Common Stock | 6k | $0.00 | $0 | | 06/11/2019 |
| 06/04/2019 | BIOMARIN PHARMACEUTICAL INC | BMRN | Grant | Common Stock | 4.4k | $0.00 | $0 | | 06/04/2019 |
| 09/13/2018 | BIOMARIN PHARMACEUTICAL INC | BMRN | Sale | Common Stock | 2.8k | $99.24 | $277.9k | | 09/13/2018 |
| 09/13/2018 | BIOMARIN PHARMACEUTICAL INC | BMRN | Sale | Common Stock | 200 | $99.25 | $19.8k | | 09/13/2018 |
| 09/13/2018 | BIOMARIN PHARMACEUTICAL INC | BMRN | Exercise | Stock Option (Right to buy Common Stock) | 3k | $21.51 | $64.5k | | 09/13/2018 |
|